|
Volumn 4, Issue 4, 2000, Pages 401-406
|
Bradykinin antagonists: New opportunities
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLILLUSTROL;
ACETYLLYSYLBRADYKININ[7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE];
ANATIBANT;
B 10056;
BENZODIAZEPINE DERIVATIVE;
BENZOTHIAZOLE DERIVATIVE;
BRADYKININ ANTAGONIST;
BRADYKININ B1 RECEPTOR ANTAGONIST;
BRADYKININ B2 RECEPTOR;
BRADYKININ B2 RECEPTOR ANTAGONIST;
BRADYZIDE;
CETIRIZINE;
DELTIBANT;
FR 172357;
ICATIBANT;
LF 16 0335C;
MEN 11270;
MEN 11575;
PS 020990;
QUINOLINE DERIVATIVE;
UNCLASSIFIED DRUG;
BACTERIAL INFECTION;
COMPETITIVE INHIBITION;
DRUG ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG CONFORMATION;
DRUG EFFECT;
DRUG INHIBITION;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STABILITY;
HUMAN;
INFLAMMATION;
NONHUMAN;
PAIN;
REVIEW;
TISSUE INJURY;
|
EID: 0033866867
PISSN: 13675931
EISSN: None
Source Type: Journal
DOI: 10.1016/S1367-5931(00)00107-1 Document Type: Review |
Times cited : (59)
|
References (39)
|